Foresite Capital Management II as of March 31, 2018
Portfolio Holdings for Foresite Capital Management II
Foresite Capital Management II holds 11 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aimmune Therapeutics | 35.1 | $106M | 3.3M | 31.83 | |
| Aerie Pharmaceuticals | 30.2 | $91M | 1.7M | 54.25 | |
| Epizyme | 9.2 | $28M | 1.6M | 17.75 | |
| Insmed (INSM) | 7.2 | $22M | 968k | 22.52 | |
| Alder Biopharmaceuticals | 7.1 | $21M | 1.7M | 12.70 | |
| Aimmune Therapeutics Inc put | 4.6 | $14M | 438k | 31.74 | |
| Acceleron Pharma | 3.2 | $9.6M | 245k | 39.10 | |
| Adaptimmune Therapeutics (ADAP) | 1.5 | $4.5M | 400k | 11.23 | |
| Denali Therapeutics (DNLI) | 1.2 | $3.7M | 250k | 14.79 | |
| Sangamo Biosciences (SGMO) | 0.3 | $877k | 46k | 19.01 | |
| Ardelyx (ARDX) | 0.3 | $808k | 160k | 5.05 |
